Skip to content

PAEME pharma

Active Private limited companyfounded 2009active for 17 yearsDikkebeuklaan 115, 1020 BrusselsKBO/BCE: BE 0812.307.989

Lifetime

16 annual accounts with figures on one time axis
peak of €154,600 in 2019
€19,477▼ 63.3%
peak of €100,101 in 2019
€9,150▼ 72.2%
peak of €537,623 in 2025
€537,623▲ 1.7%
€69,466▼ 2.2%
Board1 name since 2021
1 director
Documentsfilings and deeds
04-07-202627 days before the deadline
2025abbreviated format
Gross margin from €53,014 to €19,477Result from €32,934 to €9,150Investments €1,307Cash from €124,583 to €47,330

Key points

from the 2025 annual accounts

Equity

€537,623 ▲ 1.7%

PAEME pharma has made a profit in every financial year since 2010.

Investments

€1,307 4.8 times depreciation
20212025

Green is investment, beige is depreciation.

Filings

16 annual accounts since 2010
AprilJune31 JulyOctober2010201520202025

Two of the last ten came late. The 2019 accounts came in latest, 31 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • founderdeed of 18-06-2009

Shares in 1 company,

Board & ownership

Recent changes

changes role from director, formerly manager to director Discharge granted to · General meeting of 21-12-2023 · Gazette deed
Registered office moved from Galmaarden to Brussels The registered office moved from Oulstbergstraat 8, 1570 Galmaarden to Dikkebeuklaan 115 bus 10, 1020 Brussel · Gazette deed
Incorporation Founding capital of €18,600, 100 shares · Founded by · appointed as manager · published on 18-06-2009 · Gazette deed
First establishment At the time the registered office was still in Galmaarden, Oulstbergstraat 8.
All 27 events

Comparable companies

same main activity, similar in size and age
Company
PAEME pharma Brussels €607,089 €19,477 88.6% -
BREVEXCO Uccle €699,276 €19,181 87.3% -
NEW VISTA INVESTMENT Brussels €498,939 €20,078 53.9% -
S.E.D. MANAGEMENT Etterbeek €734,883 €19,244 85.0% -
M&B Projects Tienen €707,752 €18,803 -9.6% -
SOCIETE DE RECHERCHE ET DE CONSULTANCE EN SANTE Jalhay €612,309 €22,891 99.7% -
WINCS Grobbendonk €698,589 €20,105 22.5% -

These companies have the same main activity as PAEME pharma: business and other management consultancy (NACE 70200). They are comparable in size and age: total assets between €499,000 and €735,000, founded between 2007 and 2010.

Official details

Source: KBO
Status
Active since 16-06-2009Normal situation
Activity
Business and other management consultancyNACE 70200
Establishment unit
2.179.153.9931020 Brussels, registered on 16-06-2009
Financial year end
31 December
Peppol
Reachable via Peppol
Company details

Annual accounts 2025

≈ €82,000estimated
€607,089▲ 1.3%
Filing
Filed on 04-07-2026, 27 days before the end of the filing period
Financials

Insights on PAEME pharma

PAEME pharma files the abbreviated format. That format states no turnover. The gross margin rose from €19,141 in 2010 to €19,477 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about PAEME pharma

What is the company number of PAEME pharma?
The company number of PAEME pharma is 0812.307.989. The VAT number is the same number with BE in front: BE 0812.307.989.
Where is PAEME pharma based?
The registered office is at Dikkebeuklaan 115, 1020 Brussels.Company details
What does PAEME pharma do?
According to the KBO register, the main activity is business and other management consultancy (NACE 70200).
What is the legal form of PAEME pharma?
PAEME pharma is a private limited company (BV).
When was PAEME pharma founded?
PAEME pharma was founded on 16-06-2009.
Is PAEME pharma still active?
Yes, PAEME pharma is an active enterprise in the KBO register.
What is the turnover of PAEME pharma?
The turnover in financial year 2025 is about €82,000. This figure is estimated from the gross margin of €19,477 and 92 comparable companies (NACE 70200). It probably lies between €39,000 and €210,000. It is a rough estimate.Financials
Is PAEME pharma profitable?
In financial year 2025, PAEME pharma made a profit of €9,150.
Where can I find the annual accounts of PAEME pharma?
PAEME pharma filed 16 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of PAEME pharma due?
PAEME pharma must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.